Adalimumab Biosimilar
Autoimmune Disorders
Key Facts
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited is a research-driven global pharmaceutical company founded in 1977 and headquartered in Mumbai, India. The company operates across the pharmaceutical value chain with significant investments in R&D, particularly in respiratory diseases, dermatology, and oncology. Glenmark has successfully developed and commercialized innovative drugs while building a strong generic pharmaceuticals portfolio across key markets including the US, Europe, and emerging markets.
View full company profileAbout Changchun High-Tech Industry
Changchun High-Tech is a prominent, revenue-generating biopharmaceutical enterprise in China, primarily known for its vaccine business. Its strategic position is anchored by its controlling stake in Changchun BCHT Biotechnology, a critical supplier of the Varicella vaccine in the domestic market. The company leverages this established commercial foundation to invest in and develop a broader pipeline of biological products, including monoclonal antibodies and other innovative therapeutics. As a publicly listed entity, it operates with a diversified business model that also includes investments in real estate and other industries.
View full company profileTherapeutic Areas
Other Autoimmune Disorders Drugs
| Drug | Company | Phase |
|---|---|---|
| Humira | Royalty Pharma | Commercial |
| Immunomodulation Programs | Fosun Pharma | Various Phases |
| Autoimmune Disease Programs | TScan Therapeutics | Discovery |
| Autoimmune Diagnostics (Immco) | Trinity Biotech | Approved/Commercial |
| TYK2 Pseudokinase Inhibitor | A2A Pharma | Preclinical |